Become a Readings Member to make your shopping experience even easier. Sign in or sign up for free!

Become a Readings Member. Sign in or sign up for free!

Hello Readings Member! Go to the member centre to view your orders, change your details, or view your lists, or sign out.

Hello Readings Member! Go to the member centre or sign out.

Pharmacy Use and Costs in Employer-provided Health Plans: Insights for TRICARE Benefit Design from the Private Sector
Paperback

Pharmacy Use and Costs in Employer-provided Health Plans: Insights for TRICARE Benefit Design from the Private Sector

$70.99
Sign in or become a Readings Member to add this title to your wishlist.

Assesses how changing to a three-tiered co-payment system would affect drug costs and pharmacy utilization, in particular for specific high-cost classes of medications; As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department of Defense is considering moving from a two-tiered to a three-tiered co-payment system, which will increase the co-payment for some classes and brands of drugs. Providers would, theoretically, have an incentive to prescribe less-costly options. To predict how this move would affect costs and pharmacy utilization, the authors use an existing data resource to determine how beneficiaries age 45 to 64 in private-sector health plans responded to similar changes.

Read More
In Shop
Out of stock
Shipping & Delivery

$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout

MORE INFO
Format
Paperback
Publisher
RAND
Country
United States
Date
21 April 2005
Pages
104
ISBN
9780833035493

Assesses how changing to a three-tiered co-payment system would affect drug costs and pharmacy utilization, in particular for specific high-cost classes of medications; As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department of Defense is considering moving from a two-tiered to a three-tiered co-payment system, which will increase the co-payment for some classes and brands of drugs. Providers would, theoretically, have an incentive to prescribe less-costly options. To predict how this move would affect costs and pharmacy utilization, the authors use an existing data resource to determine how beneficiaries age 45 to 64 in private-sector health plans responded to similar changes.

Read More
Format
Paperback
Publisher
RAND
Country
United States
Date
21 April 2005
Pages
104
ISBN
9780833035493